Pubblicazioni

Timing and Impact of Psychiatric, Cognitive, and Motor Abnormalities in Huntington Disease

2021 - NEUROLOGY

McAllister, B.; Gusella, J. F.; Landwehrmeyer, G. B.; Lee, J. -M.; MacDonald, M. E.; Orth, M.; Rosser, A. E.; Williams, N. M.; Holmans, P.; Jones, L.; Massey, T. H.; the REGISTRY Investigators of the European Huntingtonâs Disease, Network; Romano, S.

No evidence for an effect on brain atrophy rate of atorvastatin add-on to interferon ÃÂ²1b therapy in relapsing-remitting multiple sclerosis (the ARIANNA study)

2016 - MULTIPLE SCLEROSIS

Lanzillo, Roberta; Quarantelli, Mario; Pozzilli, Carlo; Trojano, Maria; Amato, Maria Pia; Marrosu, Maria G.; Francia, Ada; Florio, Ciro; Orefice, Giuseppe; Tedeschi, Gioacchino; Bellantonio, Paolo; Annunziata, Pasquale; Grimaldi, Luigi M.; Comerci, Marco; Brunetti, Arturo; Bonavita, Vincenzo; Alfano, Bruno; Marini, Stefano; Brescia Morra, Vincenzo

Pubblicazioni

Timing and Impact of Psychiatric, Cognitive, and Motor Abnormalities in Huntington Disease

No evidence for an effect on brain atrophy rate of atorvastatin add-on to interferon ÃÂ²1b therapy in relapsing-remitting multiple sclerosis (the ARIANNA study)

No evidence for an effect on brain atrophy rate of atorvastatin add-on to interferon ÃÂ²1b therapy in relapsing-remitting multiple sclerosis (the ARIANNA study)